Cetyl palmitate

First approved in 1970

Details

Stereochemistry	ACHIRAL
Molecular Formula	C32H64O2
Molecular Weight	480.8494
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC

InChI

InChIKey=PXDJXZJSCPSGGI-UHFFFAOYSA-N

InChI=1S/C32H64O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-34-32(33)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-31H2,1-2H3

HIDE SMILES / InChI

Molecular Formula	C32H64O2
Molecular Weight	480.8494
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ulprospector.com/en/na/PersonalCare/Detail/4230/197479/Cetyl-Palmitate-C1203 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20428s13lbl.pdf

Cetyl Palmitate, wax-like substance, is used as an inactive ingredient in different cosmetic and personal care products e.g., in FINEVIN. This cream is used for the treatment of mild to moderate acne vulgaris. Cetyl Palmitate also functions as a binder to provide adhesive qualities during and after compression to make tablets or cakes.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Acne Vulgaris 3 Sources: https://www.ulprospector.com/en/na/PersonalCare/Detail/4230/197479/Cetyl-Palmitate-C1203 http://www.cosmeticsinfo.org/ingredient/cetyl-palmitate	Inactive ingredient		Approved 8583	FINEVIN Approved Use FINEVIN, a twice-daily topical azelaic acid cream, has been approved for the treatment of mild to moderate acne vulgaris.

PubMed

Title	Date	PubMed
Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.	2010-10-08	20823498
Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency.	2010-09	20184417
Progress in antiretroviral drug delivery using nanotechnology.	2010-08-09	20957115
Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles.	2010-05-05	19836439
Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.	2010-05	20460792
Chemical and structural investigation of lipid nanoparticles: drug-lipid interaction and molecular distribution.	2010-03-26	20182010
Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations.	2010	21092706
Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.	2009-09-10	19591929
Solid lipid nanoparticles: a modern formulation approach in drug delivery system.	2009-07	20502539
Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC.	2008-06-04	18423768
The effect of cetyl palmitate crystallinity on physical properties of gamma-oryzanol encapsulated in solid lipid nanoparticles.	2008-03-05	21817683
In vitro skin permeation of sunscreen agents from O/W emulsions.	2008-02	18377631
Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.	2007-08	17346953
[Immobilization of lipase by chemical modification of chitosan].	2007-07	17822041
A water activity control system for enzymatic reactions in organic media.	2007-06-01	17096388
Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.	2007-04-20	17161566
Oral insulin delivery by means of solid lipid nanoparticles.	2007	18203440
Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.	2007	18203427
Solid lipid nanoparticles (SLN)--effects of lipid composition on in vitro degradation and in vivo toxicity.	2006-06	16826974
Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).	2005-05-13	15848010
Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique.	2005-01-20	15620868
Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties.	2002-03	11879997
The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole.	2002	12916929
Solid lipid nanoparticles (SLN)--a novel carrier for UV blockers.	2001-10	11683123
Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits.	2001-09	11522481
Encapsulation of retinoids in solid lipid nanoparticles (SLN).	2001-03-20	11253932

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:33:56 GMT 2025` Edited by `admin` on `Mon Mar 31 17:33:56 GMT 2025`
Record UNII	5ZA2S6B08X
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CETYL PALMITATE [MI]

Preferred Name

English

Cetyl palmitate

Official Name

English

CETYL PALMITATE [USP-RS]

Common Name

English

CETYL PALMITATE [MART.]

Common Name

English

Cetyl palmitate [WHO-DD]

Common Name

English

CETYL PALMITATE [II]

Common Name

English

CETYL PALMITATE [EP MONOGRAPH]

Common Name

English

CETYL PALMITATE [VANDF]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C492